Estimates say that by 2050, 1 in 3 people will suffer from one form of diabetes or another. Israeli biotech has responded to the spread of this chronic disease from a number of different angles. Today, host Viva Press meets Nadav Kidron, CEO of Oramed[www.oramed.com], the company behind the insulin oral pill; Gadi Levin, CFO of Labstyle Innovations, who produce a mobile app for blood glucose testing called myDiario [mydario.com], and Ishai Knoble, co-founder and CEO of Helparound [helparound.co], an app that connects diabetic communities in times of emergency.
Music: Matok Matok by Yigal Bashan
— ISRAEL21c on TLV1
|
Login or Sign up to leave a comment.